Ranolazine prevents pressure overload-induced cardiac hypertrophy and heart failure by restoring aberrant Na+ and Ca2+ handling
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ranolazine prevents pressure overload-induced cardiac hypertrophy and heart failure by restoring aberrant Na+
and Ca2+
handling
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-11-29
DOI
10.1002/jcp.27791
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy
- (2018) Iacopo Olivotto et al. Circulation-Heart Failure
- Elevated local [Ca2+] and CaMKII promote spontaneous Ca2+release in ankyrin-B-deficient hearts
- (2016) Iuliana Popescu et al. CARDIOVASCULAR RESEARCH
- Long-term administration of ranolazine attenuates diastolic dysfunction and adverse myocardial remodeling in a model of heart failure with preserved ejection fraction
- (2016) Antonella De Angelis et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Cell cycle and apoptosis regulation by NFAT transcription factors: new roles for an old player
- (2016) G P Mognol et al. Cell Death & Disease
- Ranolazine antagonizes catecholamine-induced dysfunction in isolated cardiomyocytes, but lacks long-term therapeutic effectsin vivoin a mouse model of hypertrophic cardiomyopathy
- (2015) Frederik Flenner et al. CARDIOVASCULAR RESEARCH
- Late INa increases diastolic SR-Ca2+-leak in atrial myocardium by activating PKA and CaMKII
- (2015) Thomas H. Fischer et al. CARDIOVASCULAR RESEARCH
- Voltage-Gated Sodium Channel Phosphorylation at Ser571 Regulates Late Current, Arrhythmia, and Cardiac Function In VivoCLINICAL PERSPECTIVE
- (2015) Patric Glynn et al. CIRCULATION
- Diltiazem Treatment for Pre-Clinical Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers
- (2015) Carolyn Y. Ho et al. JACC-Heart Failure
- Ranolazine improves diastolic function in spontaneously hypertensive rats
- (2014) Sarah Williams et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension
- (2014) Marcella Rocchetti et al. CARDIOVASCULAR RESEARCH
- Treatment for calcium channel blocker poisoning: A systematic review
- (2014) M. St-Onge et al. CLINICAL TOXICOLOGY
- Ca 2+ /Calmodulin-Dependent Protein Kinase II and Protein Kinase A Differentially Regulate Sarcoplasmic Reticulum Ca 2+ Leak in Human Cardiac Pathology
- (2013) Thomas H. Fischer et al. CIRCULATION
- Ca2+ Fluxes Involvement in Gene Expression During Cardiac Hypertrophy
- (2013) Ana Gomez et al. Current Vascular Pharmacology
- Role of late sodium current as a potential arrhythmogenic mechanism in the progression of pressure-induced heart disease
- (2013) Karl Toischer et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Coping with Endoplasmic Reticulum Stress in the Cardiovascular System
- (2012) Jody Groenendyk et al. Annual Review of Physiology
- Late Sodium Current Inhibition Reverses Electromechanical Dysfunction in Human Hypertrophic Cardiomyopathy
- (2012) Raffaele Coppini et al. CIRCULATION
- Ranolazine stabilizes cardiac ryanodine receptors: A novel mechanism for the suppression of early afterdepolarization and torsades de pointes in long QT type 2
- (2012) Ashish Parikh et al. HEART RHYTHM
- Functional Cross-Talk Between Aldosterone and Angiotensin-(1-7) in Ventricular Myocytes
- (2012) Pedro W. Machado de Almeida et al. HYPERTENSION
- Impaired left ventricular systolic function reserve limits cardiac output and exercise capacity in HFpEF patients due to systemic hypertension
- (2012) Michael Henein et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- MFEprimer-2.0: a fast thermodynamics-based program for checking PCR primer specificity
- (2012) Wubin Qu et al. NUCLEIC ACIDS RESEARCH
- Role of ranolazine in angina, heart failure, arrhythmias, and diabetes
- (2011) Samuel Sossalla et al. PHARMACOLOGY & THERAPEUTICS
- β-AR Blockers Suppresses ER Stress in Cardiac Hypertrophy and Heart Failure
- (2011) Li Ni et al. PLoS One
- Improvement in Left Ventricular Systolic and Diastolic Performance During Ranolazine Treatment in Patients With Stable Angina
- (2010) Vincent M. Figueredo et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- B-Type Natriuretic Peptide and the Effect of Ranolazine in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes
- (2010) David A. Morrow et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Transverse Aortic Constriction in Mice
- (2010) Angela C. deAlmeida et al. Jove-Journal of Visualized Experiments
- Ranolazine combined with enalapril or metoprolol prevents progressive LV dysfunction and remodeling in dogs with moderate heart failure
- (2008) Sharad Rastogi et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started